多药耐药菌感染患者临床资料分析与预测
An analysis and predict on clinical surveillancedate of multidrug-resistance organism infection
-
摘要: 目的 分析医院多药耐药菌的流行特点,为降低和控制多药耐药菌感染提供依据。方法 选取2013年1月-2014年12月7 443例住院患者送检标本,采用法国梅里埃公司VITEK-2 Compact全自动细菌分析仪进行相关检测分析,数据采用SPSS17.0统计软件进行分析。结果 7 443例住院患者送检标本,1769例检测阳性,阳性率为23.77%;检出多药耐药菌666株,检出率为37.65%;多药耐药菌以产ESBLs大肠埃希菌为主320株占48.05%,其次为多药耐药鲍氏不动杆菌152株占22.08%;在科室分布中,多药耐药菌具有明显科室特点,如ICU的鲍氏不动杆菌占57.89%、外科系统的产ESBLs肠杆菌占45.94%、骨科、烧伤科等具有创面的MRSA占48.84%。结论 多药耐药菌感染可根据感染部位、患者基础情况以及入住科室进行预测。Abstract: OBJECTIVE To analyze the epidemic characteristics of multidrug resistant organisms,so as to provide medical evidence for prevention and control of multidrug-resistance organism(MDRO)infection.METHODS A total of 7443 samples from hospitalized patients were collected from Jan.2013 to Apr.2014.Automatic bacteria analyzer(VITEK2Compact,Merieux Company,France)was used to analyze the samples.And all data were analyzed by using SPSS17.0.RESULTS A total of 1769 strains of samples were positive from the 7443 strains of samples,and the positive rate was 23.77%.A total of 666 strains of MDRO were isolated and the detection rate was37.65%.The main MDRO was 320 strains of ESBLs producing Escherichia coli,accounting for 48.04%,followed by 152 strains of MDRO Acinetobacter baumanni,accounting for 22.08%.In different departments,there were obvious characters for MDRO,the A.baumannii accounted for 57.89% in ICU,and ESBLs producing E.coli accounted for 45.94%in surgery systems,MRSA with wound surface department of orthopaedics,burn department accounted for 48.84%.CONCLUSION The MDRO could be predicted by infection sites,the basic status of patients and departments.
下载: